Cargando…
An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome
INTRODUCTION: Comprehensive genetic analysis is essential to clinical care of patients with atypical haemolytic uremic syndrome (aHUS) to reinforce diagnosis, and to guide treatment. However, the characterization of complement gene variants remains challenging owing to the complexity of functional s...
Autores principales: | Gastoldi, Sara, Aiello, Sistiana, Galbusera, Miriam, Breno, Matteo, Alberti, Marta, Bresin, Elena, Mele, Caterina, Piras, Rossella, Liguori, Lucia, Santarsiero, Donata, Benigni, Ariela, Remuzzi, Giuseppe, Noris, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949374/ https://www.ncbi.nlm.nih.gov/pubmed/36845135 http://dx.doi.org/10.3389/fimmu.2023.1112257 |
Ejemplares similares
-
Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant
por: Piras, Rossella, et al.
Publicado: (2020) -
CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome
por: Piras, Rossella, et al.
Publicado: (2023) -
C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19
por: Aiello, Sistiana, et al.
Publicado: (2022) -
Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS
por: Valoti, Elisabetta, et al.
Publicado: (2019) -
CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis
por: Piras, Rossella, et al.
Publicado: (2021)